BSE - Delayed Quote INR
Tatva Chintan Pharma Chem Limited (TATVA.BO)
725.65
-35.75
(-4.70%)
At close: April 25 at 3:29:53 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
--
980,440
277,830
202,300
194,920
Investing Cash Flow
--
-1,205,400
-1,011,440
-1,966,860
-205,830
Financing Cash Flow
--
305,190
377,950
2,350,100
-45,840
End Cash Position
--
353,040
273,650
630,170
44,810
Capital Expenditure
--
-1,285,150
-2,031,100
-891,570
-209,680
Issuance of Capital Stock
--
12,270
--
2,111,030
--
Issuance of Debt
--
--
8,290
422,850
179,570
Repayment of Debt
--
-86,580
-139,370
-134,260
-184,200
Free Cash Flow
--
-304,710
-1,753,270
-689,270
-14,760
3/31/2021 - 7/29/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade